VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
GLP-1's New Battlefield: Hengrui's HRS-7535 Enters Phase III for Chronic Kidney Disease
GLP-1's New Battlefield: Hengrui's HRS-7535 Enters Phase III for Chronic Kidney Disease
Jun 09, 2026 12:00 CST Updated 14:25
Share:
Hengrui Pharma
Innovative and High-Quality Pharmaceutical Developer